Halozyme CEO Helen Torley disposes of 48,000 common shares worth $5.31 million
Bitget2026/10/08 23:57Halozyme filed a Form 4 showing President and CEO Helen Torley exercised options for 60,000 shares at $18.41 on Oct. 6-8. She sold 60,000 shares over the same period at weighted-average prices ranging from $107.902 to $112.78. Directly owned common shares held were unchanged at 767,780 following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Halozyme Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001159036-26-000140), on October 08, 2026, and is solely responsible for the information contained therein.
- Halozyme filed a Form 4 showing President and CEO Helen Torley exercised options for 60,000 shares at $18.41 on Oct. 6-8.
- She sold 60,000 shares over the same period at weighted-average prices ranging from $107.902 to $112.78.
- Directly owned common shares held were unchanged at 767,780 following the transactions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Banks head for $5 billion gold trading windfall in record year
Ripple Breaks Into Wall Street With Native Brokerage
These 5 Bitcoin Indicators Have Turned Bullish for the First Time Since 2025: Report
HSBC, Ant Digital test AI-agent payments using tokenized deposits
Crypto prices
More
